Internal Medicine, Medical Oncology · Winter Park, FL
NPI
1336466622
Since 2010
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
460 N Orlando Ave, Ste 200 Bldg D
Winter Park, FL, 32789
Phone (407) 898-5452
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.8M
211,878 services
Medicare patients, 2024
634
Average age 74
Drug cost, 2024
$6.2M
2,891 prescriptions
Company payments, 2025
$3,295
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Muhammad H Imam was code J9299 (injection, nivolumab, 1 mg), 31,340 times for 11 patients. In total Muhammad H Imam billed 211,878 services in 154 codes, and Medicare paid $4.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9299 Injection, nivolumab, 1 mg | Office | 31,340 | 11 | $24.64 | $772K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 18,200 | 17 | $44.60 | $812K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 4,340 | 15 | $6.36 | $28K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,519 | 45 | $0.09 | $227 |
| 85025 Blood Count | Office | 1,751 | 506 | $7.60 | $13K |
| 36415 Venipuncture Blood Collection | Office | 1,703 | 505 | $8.64 | $15K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,400 | 12 | $15.41 | $22K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,330 | 23 | $0.73 | $969 |
| J0897 Injection, denosumab, 1 mg | Office | 1,320 | 16 | $20.58 | $27K |
| 99214 Office E&M - Established | Office | 818 | 296 | $96.08 | $79K |
| 96375 Injection Administration | Office | 751 | 75 | $11.29 | $8,480 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 678 | 350 | $12.68 | $8,595 |
| J1750 Injection, iron dextran, 50 mg | Office | 636 | 23 | $13.81 | $8,781 |
| 96413 Chemotherapy Administration | Office | 573 | 77 | $94.48 | $54K |
| J9045 Injection, carboplatin, 50 mg | Office | 404 | 14 | $2.80 | $1,133 |
By year: 2022 $3.8M for 204,939 services; 2023 $3.7M for 185,486 services; 2024 $4.8M for 211,878 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,751 | 506 | $7.60 | $13K |
| 36415 Venipuncture Blood Collection | 1,703 | 505 | $8.64 | $15K |
| 85610 Clinical Chemistry | 77 | 12 | $4.20 | $323 |
| 85045 Blood Count | 57 | 54 | $3.91 | $223 |
| 81003 Clinical Chemistry | 30 | 18 | $2.20 | $66 |
Medicare prescription drug claims, 2024
In 2024, the drug Muhammad H Imam prescribed most often to Medicare patients was Letrozole, with 171 prescriptions and refills. In total Muhammad H Imam wrote 2,891 Medicare prescriptions that cost $6.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 171 | 427 | 50 | $4,242 |
| Anastrozole Generic | 158 | 441 | 52 | $2,705 |
| Prednisone Generic | 133 | 178 | 49 | $833 |
| Eliquis Apixaban | 106 | 128 | 27 | $73K |
| Gabapentin Generic | 103 | 149 | 28 | $1,244 |
| Acyclovir Generic | 66 | 94 | 14 | $695 |
| Ondansetron Hcl Generic | 60 | 60 | 43 | $1,048 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 58 | 135 | 14 | $923 |
| Alprazolam Generic | 54 | 54 | 16 | $216 |
| Pantoprazole Sodium Generic | 54 | 116 | 21 | $337 |
| Exemestane Generic | 54 | 89 | 15 | $6,001 |
| Xarelto Rivaroxaban | 51 | 95 | 12 | $51K |
| Oxycodone Hcl Generic | 50 | 50 | 13 | $2,623 |
| Revlimid Lenalidomide | 50 | 50 | Under 11 | $895K |
| Levothyroxine Sodium Generic | 48 | 115 | 13 | $380 |
Brand drugs: 688 claims; generic drugs: 2,203 claims; opioid claims: 216.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Muhammad H Imam $3,295 ($3,295 in general payments such as food, travel and fees) from 27 companies. The largest payer was Janssen Global Services, LLC with $1,540.
| Company | Payments | Amount |
|---|---|---|
| Janssen Global Services, LLC JNJ | 1 | $1,540 |
| BeOne Medicines USA, Inc. ONC | 10 | $285 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $200 |
| Abbvie Inc. ABBV | 5 | $135 |
| Merck Sharp & Dohme LLC MRK | 4 | $118 |
| Astellas Pharma US Inc 4503.T | 5 | $100 |
| Celgene Corporation BMY | 3 | $97.54 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $87.3 |
| GlaxoSmithKline, LLC. GSK | 4 | $81.66 |
| Janssen Biotech, Inc. JNJ | 4 | $79.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.